GeniPhys wins nearly $1M grant to commercialize tissue restoration technology

A life sciences company in West Lafayette has received a National Science Foundation grant worth nearly $1 million to focus on developing and commercializing a biopolymer technology developed by Purdue University professor Sherry Harbin.

GeniPhys Inc. was awarded the $974,349 grant to further the development of a core technology known as Collymer. It can be used to create implantable materials for tissue restoration and reconstruction needs such as breast tissue, skeletal muscle, cartilage and more.

Collymer materials harness both the mechanical and biochemical signaling features of natural collagen found within tissues, according to a press release from Purdue University. This allows the materials to support regenerative and restorative healing without rapidly degrading and eliciting inflammation or other responses to foreign material in the body.

GeniPhys CEO Andy Eibling said the company is excited to be able to use the grant to advance the technology toward submission to the U.S. Food and Drug administration for review and commercialization.

“We believe the Collymer platform will have a tremendous impact for patients globally, and this grant is an important step in the process,” Eibling said in a written statement.

GeniPhys previously received a $225,000 National Science Foundation grant to evaluate Collymer prototypes for breast tissue restoration.

The new grant will allow GeniPhys to scale up manufacturing capabilities for commercialization.

Please enable JavaScript to view this content.

Story Continues Below

Editor's note: You can comment on IBJ stories by signing in to your IBJ account. If you have not registered, please sign up for a free account now. Please note our updated comment policy that will govern how comments are moderated.

{{ articles_remaining }}
Free {{ article_text }} Remaining
{{ articles_remaining }}
Free {{ article_text }} Remaining Article limit resets on
{{ count_down }}